LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 77

Search options

  1. Article ; Online: Non-Haemodynamic Mechanisms Underlying Hypertension-Associated Damage in Target Kidney Components.

    Russo, Elisa / Bussalino, Elisabetta / Macciò, Lucia / Verzola, Daniela / Saio, Michela / Esposito, Pasquale / Leoncini, Giovanna / Pontremoli, Roberto / Viazzi, Francesca

    International journal of molecular sciences

    2023  Volume 24, Issue 11

    Abstract: Arterial hypertension (AH) is a global challenge that greatly impacts cardiovascular morbidity and mortality worldwide. AH is a major risk factor for the development and progression of kidney disease. Several antihypertensive treatment options are ... ...

    Abstract Arterial hypertension (AH) is a global challenge that greatly impacts cardiovascular morbidity and mortality worldwide. AH is a major risk factor for the development and progression of kidney disease. Several antihypertensive treatment options are already available to counteract the progression of kidney disease. Despite the implementation of the clinical use of renin-angiotensin aldosterone system (RAAS) inhibitors, gliflozins, endothelin receptor antagonists, and their combination, the kidney damage associated with AH is far from being resolved. Fortunately, recent studies on the molecular mechanisms of AH-induced kidney damage have identified novel potential therapeutic targets. Several pathophysiologic pathways have been shown to play a key role in AH-induced kidney damage, including inappropriate tissue activation of the RAAS and immunity system, leading to oxidative stress and inflammation. Moreover, the intracellular effects of increased uric acid and cell phenotype transition showed their link with changes in kidney structure in the early phase of AH. Emerging therapies targeting novel disease mechanisms could provide powerful approaches for hypertensive nephropathy management in the future. In this review, we would like to focus on the interactions of pathways linking the molecular consequences of AH to kidney damage, suggesting how old and new therapies could aim to protect the kidney.
    MeSH term(s) Humans ; Hypertension ; Kidney/metabolism ; Renin-Angiotensin System ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/metabolism ; Hypertension, Renal/metabolism
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2023-05-29
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24119422
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Blood pressure phenotype: an evolving picture.

    Leoncini, Giovanna / Viazzi, Francesca / Bonino, Barbara / Pontremoli, Roberto

    Internal and emergency medicine

    2019  Volume 15, Issue 1, Page(s) 19–20

    MeSH term(s) Blood Pressure ; Humans ; Phenotype ; Renal Insufficiency, Chronic ; Reproducibility of Results
    Language English
    Publishing date 2019-07-24
    Publishing country Italy
    Document type Journal Article ; Comment
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-019-02157-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Uric acid in CKD: has the jury come to the verdict?

    Bonino, Barbara / Leoncini, Giovanna / Russo, Elisa / Pontremoli, Roberto / Viazzi, Francesca

    Journal of nephrology

    2020  Volume 33, Issue 4, Page(s) 715–724

    Abstract: Epidemiological studies show that hyperuricemia independently predicts the development of chronic kidney disease (CKD) in individuals with normal kidney function both in the general population and in subjects with diabetes. As a matter of fact, an ... ...

    Abstract Epidemiological studies show that hyperuricemia independently predicts the development of chronic kidney disease (CKD) in individuals with normal kidney function both in the general population and in subjects with diabetes. As a matter of fact, an unfavorable role of uric acid may somewhat be harder to identify in the context of multiple risk factors and pathogenetic mechanisms typical of overt CKD such as proteinuria and high blood pressure. Although the discrepancy in clinical results could mean that urate lowering treatment does not provide a constant benefit in all patients with hyperuricemia and CKD, we believe that the inconsistency in the results from available meta-analysis is mainly due to inadequate sample size, short follow-up times and heterogeneity in study design characterizing the randomized controlled trials included in the analyses. Therefore, available data support the view that hyperuricemia has a damaging impact on kidney function, while preliminary evidence suggests that treatment of so-called asymptomatic hyperuricemia may be helpful to slow or delay the progression of chronic kidney.
    MeSH term(s) Disease Progression ; Humans ; Hyperuricemia ; Randomized Controlled Trials as Topic ; Renal Insufficiency, Chronic ; Risk Factors ; Uric Acid/blood
    Chemical Substances Uric Acid (268B43MJ25)
    Language English
    Publishing date 2020-01-13
    Publishing country Italy
    Document type Journal Article ; Meta-Analysis ; Review
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-020-00702-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits.

    Leoncini, Giovanna / Russo, Elisa / Bussalino, Elisabetta / Barnini, Cecilia / Viazzi, Francesca / Pontremoli, Roberto

    International journal of molecular sciences

    2021  Volume 22, Issue 9

    Abstract: In recent years, following the publication of results from several RCTs, first on cardiovascular and more recently on renal outcomes, SGLT2is have become the standard of care to prevent diabetic kidney disease and slow its progression. This narrative ... ...

    Abstract In recent years, following the publication of results from several RCTs, first on cardiovascular and more recently on renal outcomes, SGLT2is have become the standard of care to prevent diabetic kidney disease and slow its progression. This narrative review focuses on biological mechanisms, both renal and extrarenal, underlying kidney protection with SGLT2is. Furthermore, data from cardiovascular as well as renal outcome trials, mostly conducted in diabetic patients, are presented and discussed to provide an overview of current uses as well as the future therapeutic potential of these drugs.
    MeSH term(s) Animals ; Diabetes Mellitus, Type 2/complications ; Diabetic Nephropathies/drug therapy ; Diabetic Nephropathies/etiology ; Diabetic Nephropathies/pathology ; Glomerular Filtration Rate ; Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use
    Chemical Substances Sodium-Glucose Transporter 2 Inhibitors
    Language English
    Publishing date 2021-04-23
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms22094441
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Treating Hyperuricemia: The Last Word Hasn't Been Said Yet.

    Russo, Elisa / Verzola, Daniela / Leoncini, Giovanna / Cappadona, Francesca / Esposito, Pasquale / Pontremoli, Roberto / Viazzi, Francesca

    Journal of clinical medicine

    2021  Volume 10, Issue 4

    Abstract: Gout as well as asymptomatic hyperuricemia have been associated with several traditional cardiovascular risk factors and chronic kidney disease. Both in vitro studies and animal models support a role for uric acid mediating both hemodynamic and tissue ... ...

    Abstract Gout as well as asymptomatic hyperuricemia have been associated with several traditional cardiovascular risk factors and chronic kidney disease. Both in vitro studies and animal models support a role for uric acid mediating both hemodynamic and tissue toxicity leading to glomerular and tubule-interstitial damage, respectively. Nevertheless, two recent well designed and carried out trials failed to show the benefit of allopurinol treatment on kidney outcomes, casting doubts on expectations of renal protection by the use of urate lowering treatment. With the aim of providing possible explanations for the lack of effect of urate lowering treatment on chronic kidney disease progression, we will critically review results from all available randomized controlled trials comparing a urate-lowering agent with placebo or no study medication for at least 12 months and report renal clinical outcomes.
    Language English
    Publishing date 2021-02-17
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm10040819
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Elderly Woman With Abnormal ECG.

    Marra, Alessio / Cattaneo, Federico / Murialdo, Giovanni / Leoncini, Giovanna

    Annals of emergency medicine

    2018  Volume 72, Issue 6, Page(s) 672–674

    MeSH term(s) Aged ; Computed Tomography Angiography ; Electrocardiography/methods ; Female ; Humans ; Myocarditis/blood ; Myocarditis/diagnostic imaging ; Troponin T/blood
    Chemical Substances Troponin T
    Language English
    Publishing date 2018-11-19
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 603080-4
    ISSN 1097-6760 ; 0196-0644
    ISSN (online) 1097-6760
    ISSN 0196-0644
    DOI 10.1016/j.annemergmed.2018.03.009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Antihypertensive treatment and renal protection: Is there a J-curve relationship?

    Viazzi, Francesca / Leoncini, Giovanna / Grassi, Guido / Pontremoli, Roberto

    Journal of clinical hypertension (Greenwich, Conn.)

    2018  Volume 20, Issue 11, Page(s) 1560–1574

    Abstract: A bidirectional relationship between hypertension and kidney disease, with one exacerbating the effect of the other, is well established. Elevated blood pressure (BP) is a well-recognized, modifiable risk factor for cardiovascular (CV) disease as well as ...

    Abstract A bidirectional relationship between hypertension and kidney disease, with one exacerbating the effect of the other, is well established. Elevated blood pressure (BP) is a well-recognized, modifiable risk factor for cardiovascular (CV) disease as well as for development and progression of chronic kidney disease and, therefore, the identification of optimal BP target is a key issue in the management of renal patients. Recent large trials and real life cohort studies have indicated that below a definite BP value renal protection seems to plateau and too low levels may even be associated with a paradoxical increase in renal morbidity, thus reviving the debate about the so called BP -renal function J-curve relationship. Existing evidence supports a systolic target around 130 mm Hg to combine both renal and CV protection and possibly lower levels in the presence of overt proteinuria.
    MeSH term(s) Adult ; Aged ; Angiotensin II Type 1 Receptor Blockers/pharmacology ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Blood Pressure/drug effects ; Cardiovascular Diseases/epidemiology ; Cardiovascular Diseases/physiopathology ; Disease Progression ; Female ; Glomerular Filtration Rate/drug effects ; Humans ; Hypertension/complications ; Hypertension/drug therapy ; Hypertension/physiopathology ; Kidney/drug effects ; Kidney/metabolism ; Kidney/physiopathology ; Male ; Middle Aged ; Proteinuria/complications ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/metabolism ; Renal Insufficiency, Chronic/physiopathology ; Renal Insufficiency, Chronic/prevention & control ; Risk Factors
    Chemical Substances Angiotensin II Type 1 Receptor Blockers ; Angiotensin-Converting Enzyme Inhibitors ; Antihypertensive Agents
    Language English
    Publishing date 2018-09-28
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2077222-1
    ISSN 1751-7176 ; 1524-6175
    ISSN (online) 1751-7176
    ISSN 1524-6175
    DOI 10.1111/jch.13396
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?

    Leoncini, Giovanna / Barnini, Cecilia / Manco, Luca / Nobili, Giulia / Dotta, Daniele / Penso, Martina / Russo, Elisa / Cappadona, Francesca / Viazzi, Francesca / Pontremoli, Roberto

    Clinical kidney journal

    2022  Volume 15, Issue 9, Page(s) 1666–1674

    Abstract: Hyperuricemia has been associated with several cardiovascular risk factors and is a well-known predictor of kidney disease. ...

    Abstract Hyperuricemia has been associated with several cardiovascular risk factors and is a well-known predictor of kidney disease.
    Language English
    Publishing date 2022-03-12
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2655800-2
    ISSN 2048-8513 ; 2048-8505
    ISSN (online) 2048-8513
    ISSN 2048-8505
    DOI 10.1093/ckj/sfac075
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations.

    Leoncini, Giovanna / Viazzi, Francesca / De Cosmo, Salvatore / Russo, Giuseppina / Fioretto, Paola / Pontremoli, Roberto

    Journal of nephrology

    2020  Volume 33, Issue 5, Page(s) 949–963

    Abstract: Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in ... ...

    Abstract Diabetic kidney disease (DKD) affects approximately one-third of patients with diabetes and taking into consideration the high cardiovascular risk burden associated to this condition a multifactorial therapeutic approach is traditionally recommended, in which glucose and blood pressure control play a central role. The inhibition of renin-angiotensin-aldosterone RAAS system represent traditionally the cornerstone of DKD. Clinical outcome trials have demonstrated clinical significant benefit in slowing nephropathy progression mainly in the presence of albuminuria. Thus, international guidelines mandate their use in such patients. Given the central role of RAAS activity in the pathogenesis and progression of renal and cardiovascular damage, a more profound inhibition of the system by the use of multiple agents has been proposed in the past, especially in the presence of proteinuria, however clinical trials have failed to confirm the usefulness of this therapeutic approach. Furthermore, whether strict blood pressure control and pharmacologic RAAS inhibition entails a favorable renal outcome in non-albuminuric patients is at present unclear. This aspect is becoming an important issue in the management of DKD since nonalbuminuric DKD is currently the prevailing presenting phenotype. For these reasons it would be advisable that blood pressure management should be tailored in each subject on the basis of the renal phenotype as well as related comorbidities. This article reviews the current literature and discusses potentials and limitation of targeting the RAAS in order to provide the greatest renal protection in DKD.
    MeSH term(s) Albuminuria/drug therapy ; Blood Pressure ; Diabetes Mellitus ; Diabetic Nephropathies/drug therapy ; Humans ; Hypotension ; Renin-Angiotensin System
    Language English
    Publishing date 2020-07-17
    Publishing country Italy
    Document type Journal Article ; Review
    ZDB-ID 1093991-x
    ISSN 1724-6059 ; 1120-3625 ; 1121-8428
    ISSN (online) 1724-6059
    ISSN 1120-3625 ; 1121-8428
    DOI 10.1007/s40620-020-00803-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.

    Russo, Elisa / Leoncini, Giovanna / Esposito, Pasquale / Garibotto, Giacomo / Pontremoli, Roberto / Viazzi, Francesca

    International journal of molecular sciences

    2020  Volume 21, Issue 12

    Abstract: Recently, there has been a growing interest in epidemiological and clinical studies supporting a pathogenetic role of fructose in cardio-metabolic diseases, especially in children and adolescents. In the present review, we summarize experimental data on ... ...

    Abstract Recently, there has been a growing interest in epidemiological and clinical studies supporting a pathogenetic role of fructose in cardio-metabolic diseases, especially in children and adolescents. In the present review, we summarize experimental data on the potential biological mechanisms linking fructose and uric acid in the development of insulin resistance, metabolic syndrome, obesity, diabetes, hypertension, non-alcoholic fatty liver disease and chronic renal disease, thereby contributing to an increase in cardiovascular risk at pediatric age.
    MeSH term(s) Cardiovascular Diseases/etiology ; Cardiovascular Diseases/metabolism ; Cardiovascular Diseases/pathology ; Child ; Diabetes Mellitus/metabolism ; Diabetes Mellitus/physiopathology ; Fructose/metabolism ; Humans ; Hypertension/complications ; Hypertension/metabolism ; Hypertension/pathology ; Insulin Resistance ; Metabolic Syndrome/complications ; Metabolic Syndrome/metabolism ; Metabolic Syndrome/pathology ; Obesity/complications ; Obesity/metabolism ; Obesity/pathology ; Risk Factors ; Uric Acid/metabolism
    Chemical Substances Uric Acid (268B43MJ25) ; Fructose (30237-26-4)
    Language English
    Publishing date 2020-06-24
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms21124479
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top